Prolonged-Release Fampridine Treatment and Walking Ability and Balance in Patients with Multiple Sclerosis: Results of the Randomized, Double-Blind MOBILE Study

被引：0
|
作者：
Lycke, Jan
Short, Christine
Gasperini, Claudio
Hupperts, Raymond
McNeil, Manjit
Medori, Rossella
Mehta, Lahar
Elkins, Jacob
机构：
来源：
NEUROLOGY | 2014年 / 83卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E36 / E36
页数：1
相关论文
共 50 条
  • [1] Prolonged-release fampridine treatment and walking ability and balance in patients with multiple sclerosis: results of the randomized, double-blind MOBILE study
    Mehta, L. R.
    Lycke, J.
    Short, C.
    Gasperini, C.
    Hupperts, R.
    McNeill, M.
    Medori, R.
    Elkins, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 192 - 192
  • [2] Prolonged-release fampridine treatment and walking ability and balance in patients with multiple sclerosis: results of the randomized, double-blind MOBILE study
    Mehta, L. R.
    Lycke, J.
    Short, C.
    Gasperini, C.
    Hupperts, R.
    McNeill, M.
    Medori, R.
    Elkins, J.
    JOURNAL OF NEUROLOGY, 2014, 261 : S134 - S134
  • [3] Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis
    Mathiesen, Henrik K.
    Sorensen, Per S.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) : 1309 - 1317
  • [4] Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine
    Jeremy Hobart
    Tjalf Ziemssen
    Peter Feys
    Michael Linnebank
    Andrew D. Goodman
    Rachel Farrell
    Raymond Hupperts
    Andrew R. Blight
    Veronica Englishby
    Manjit McNeill
    Ih Chang
    Gabriel Lima
    Jacob Elkins
    CNS Drugs, 2019, 33 : 61 - 79
  • [5] Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine
    Hobart, Jeremy
    Ziemssen, Tjalf
    Feys, Peter
    Linnebank, Michael
    Goodman, Andrew D.
    Farrell, Rachel
    Hupperts, Raymond
    Blight, Andrew R.
    Englishby, Veronica
    McNeill, Manjit
    Chang, Ih
    Lima, Gabriel
    Elkins, Jacob
    CNS DRUGS, 2019, 33 (01) : 61 - 79
  • [6] Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial
    Hupperts, Raymond
    Lycke, Jan
    Short, Christine
    Gasperini, Claudio
    McNeill, Manjit
    Medori, Rossella
    Tofil-Kaluza, Agata
    Hovenden, Maria
    Mehta, Lahar R.
    Elkins, Jacob
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (02) : 212 - 221
  • [7] Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden
    Acosta, Carlos
    Gianinazzi, Mattia
    Dort, Thibaut
    Armstrong, Nigel
    Ryder, Steve
    Lundqvist, Thomas
    Ekelund, Mats
    Lycke, Jan
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 770 - 780
  • [8] Prolonged-release fampridine as adjunct therapy to active enabled motor training in multiple sclerosis patients: a pilot, double-blind, placebo-controlled study
    Jacques, F.
    Schembri, A.
    Nativ, A.
    Paquette, C.
    Kalinowski, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 673 - 673
  • [9] Treatment of fatigue in multiple sclerosis: a phase II double-blind, randomized, mono-center, placebo-controlled crossover-sub-study on prolonged-release fampridine
    Weller, D.
    Sutter, T.
    Koeszeghi, L.
    Kapitza, S.
    Reuter, K.
    Filli, L.
    Zoerner, B.
    Farkas, M.
    Weller, M.
    Linnebank, M.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 526 - 526
  • [10] Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)
    Preiningerova, Jana Lizrova
    Baumhackl, Ulf
    Csepany, Tunde
    Czaplinski, Adam
    Deisenhammer, Florian
    Derfuss, Tobias
    Fabjan, Tanja H.
    Fazekas, Franz
    Fuchs, Siegrid
    Havrdova, Eva
    Ledinek, Alenka Horvath
    Illes, Zsolt
    Jazbec, Sasa Sega
    Klimova, Eleonora
    Komoly, Samuel
    Kurca, Egon
    Linnebank, Michael
    Lisy, Lubomir
    Mares, Jan
    Prochazkova, Lubica
    Csilla, Rozsa
    Szilasiova, Jarmila
    Stourac, Pavel
    Talab, Radomir
    Turcani, Peter
    Vachova, Marta
    Vecsei, Laszlo
    Vodusek, David
    Zapletalova, Olga
    Berger, Thomas
    CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (05) : 302 - 306
12345